5Morice MC,Serruys PW,Sousa JE,Fajadet J,Ban Hayashi E,Perin M,Colombo A,Schuler G,Barragan P,Guagliumi G,Molnàr F,Falotico R;RAVEL Study Group.A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.N Engl J Med.2002;346(23):1773-1780.
6Moses JW,Leon MB,Popma JJ,Fitzgerald PJ,Holmes DR,O'Shaughnessy C,Caputo RP,Kereiakes DJ,Williams DO,Teirstein PS,Jaeger JL,Kuntz RE;SIRIUS Investigators.Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.N Engl J Med.2003;349(14):1315-1323.
7Virmani R,Guagliumi G,Farb A,Musumeci G,Grieco N,Motta T,Mihalcsik L,Tespili M,Valsecchi O,Kolodgie FD.Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stem:should we be cautious?Circulation.2004;109(6):701-705.
8Camenzind E,Steg PG,Wijns W.Stent thrombosis late after implantation of first-generation drug-eluting stents:a cause for concern.Circulation.2007:115(11):1440-1455.
9Daemen J,Wenaweser P,Tsuchida K,Abrecht L,Vaina S,Morger C,Kukreja N.Jüni P,Sianos G,Hellige G,van Domburg RT.Hess OM,Boersma E,Meier B,Windecker S,Serruys PW.Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxeI-eluting stents in routine clinical practice:data from a large two-institutional cohort study.Lancet.2007;369(9562):667-678.
10Wenaweser P,Daemen J,Zwahlen M,van Domburg R,Jüni P,Vaina S,Hellige G,Tsuchida K,Morger C,Boersma E,Kukreja N,Meier B,Serruys PW,Windecker S.Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice:4-year results from a large 2-institutional cohort study.J Am Coll Cardiol.2008:52(14):1134-1140.
